Newsletter Archive
-
03.19.24 -- Understanding Undruggable Targets: Challenges And Progress
3/19/2024
03/19/24 Drug Discovery Online Newsletter
-
03.18.24 -- Regulatory & GMP Manufacturing Insights Into mRNA-LNP Drug Products
3/18/2024
03/18/24 Drug Discovery Online Newsletter
-
03.13.24 -- Achieving Efficient Process Development And Validation
3/13/2024
03/13/24 Drug Discovery Online Newsletter
-
03.12.24 -- The Benefits Of Using GenAI In Drug Discovery And Preclinical Development
3/12/2024
03/12/24 Drug Discovery Online Newsletter
-
03.05.24 -- Finding New Treatments In Old Therapies
3/5/2024
03/05/24 Drug Discovery Online Newsletter
-
02.27.24 -- A Patient-Centric Approach Built On The Porosome
2/27/2024
02/27/24 Drug Discovery Online Newsletter
-
02.20.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions
2/20/2024
02/20/24 Drug Discovery Online Newsletter
-
02.20.24 -- AI In Drug Discovery And Development – Will It Live Up To The Hype?
2/20/2024
02/20/24 Drug Discovery Online Newsletter
-
02.13.24 -- Animal Testing Isn't Perfect. Is There An Alternative?
2/13/2024
02/13/24 Drug Discovery Online Newsletter
-
02.06.24 -- AI's Role In Drug Discovery To Propel Personalized, Patient-Centric Medicine
2/6/2024
02/06/24 Drug Discovery Online Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more